Petra Pfisterer

961 total citations
18 papers, 803 citations indexed

About

Petra Pfisterer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Petra Pfisterer has authored 18 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Petra Pfisterer's work include T-cell and B-cell Immunology (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Petra Pfisterer is often cited by papers focused on T-cell and B-cell Immunology (4 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Petra Pfisterer collaborates with scholars based in Germany, Austria and Sweden. Petra Pfisterer's co-authors include Thomas Wirth, Peter E. Huber, Stefan Zwilling, Hubert Schorle, Harald König, Lynn M. Corcoran, Jochen Heß, Andreas Dieckmann, Peter Angel and Martin Hegen and has published in prestigious journals such as Science, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Petra Pfisterer

18 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Pfisterer Germany 15 406 229 145 122 109 18 803
Divya Sahu United States 15 644 1.6× 113 0.5× 40 0.3× 87 0.7× 238 2.2× 35 968
M. Aiman Mohtar Malaysia 16 618 1.5× 145 0.6× 59 0.4× 93 0.8× 164 1.5× 26 1.0k
Anne Shilkaitis United States 19 688 1.7× 162 0.7× 164 1.1× 93 0.8× 133 1.2× 35 1.2k
Gitte P. Ratz Denmark 14 913 2.2× 240 1.0× 66 0.5× 27 0.2× 127 1.2× 17 1.2k
Ta‐Hsu Chou United States 15 304 0.7× 238 1.0× 43 0.3× 52 0.4× 42 0.4× 37 708
Anna Jaśkiewicz Poland 12 550 1.4× 106 0.5× 43 0.3× 32 0.3× 188 1.7× 28 826
Yu‐Shan Wang Taiwan 17 253 0.6× 275 1.2× 40 0.3× 110 0.9× 100 0.9× 46 773
Derek Blair United States 14 279 0.7× 208 0.9× 48 0.3× 56 0.5× 93 0.9× 26 656
Uri Nir Israel 21 860 2.1× 138 0.6× 181 1.2× 40 0.3× 288 2.6× 56 1.3k

Countries citing papers authored by Petra Pfisterer

Since Specialization
Citations

This map shows the geographic impact of Petra Pfisterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Pfisterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Pfisterer more than expected).

Fields of papers citing papers by Petra Pfisterer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Pfisterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Pfisterer. The network helps show where Petra Pfisterer may publish in the future.

Co-authorship network of co-authors of Petra Pfisterer

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Pfisterer. A scholar is included among the top collaborators of Petra Pfisterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Pfisterer. Petra Pfisterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pfisterer, Petra, Chenxi Shen, Zaneta Nikolovska‐Coleska, et al.. (2010). In silico discovery of acylated flavonol monorhamnosides from Eriobotrya japonica as natural, small-molecular weight inhibitors of XIAP BIR3. Bioorganic & Medicinal Chemistry. 19(2). 1002–1009. 6 indexed citations
2.
Rollinger, Judith M., Denise V. Kratschmar, Daniela Schuster, et al.. (2010). 11β-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches. Bioorganic & Medicinal Chemistry. 18(4). 1507–1515. 39 indexed citations
3.
Pfisterer, Petra, et al.. (2010). Neoandrographolide fromAndrographis paniculataas a Potential Natural Chemosensitizer. Planta Medica. 76(15). 1698–1700. 21 indexed citations
4.
Pfisterer, Petra, Gerhard Wolber, Thomas Efferth, Judith M. Rollinger, & Hermann Stuppner. (2010). Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics. Current Pharmaceutical Design. 16(15). 1718–1741. 14 indexed citations
5.
Aubry, Évelyne, Zoltán Balázs, Petra Pfisterer, et al.. (2009). Inhibition of 11β-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines. Fitoterapia. 80(3). 200–205. 24 indexed citations
6.
Weber, Susanne N., et al.. (2003). Cloning, expression and characterization of the murine Efemp1, a gene mutated in Doyne–Honeycomb retinal dystrophy. Gene Expression Patterns. 3(4). 441–447. 35 indexed citations
7.
Pfisterer, Petra, et al.. (2003). Dynamic expression of Krüppel‐like factor 4 (Klf4), a target of transcription factor AP‐2α during murine mid‐embryogenesis. The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology. 273A(2). 677–680. 22 indexed citations
8.
Pfisterer, Petra, et al.. (2002). A Subtractive Gene Expression Screen Suggests a Role of Transcription Factor AP-2α in Control of Proliferation and Differentiation. Journal of Biological Chemistry. 277(8). 6637–6644. 56 indexed citations
9.
Huber, Peter E. & Petra Pfisterer. (2000). In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound. Gene Therapy. 7(17). 1516–1525. 148 indexed citations
10.
Huber, Peter, Juergen Jenne, Jürgen Debus, M. Wannenmacher, & Petra Pfisterer. (1999). A comparison of shock wave and sinusoidal-focused ultrasound-induced localized transfection of HeLa cells. Ultrasound in Medicine & Biology. 25(9). 1451–1457. 51 indexed citations
11.
Pfisterer, Petra, Jochen Heß, & Thomas Wirth. (1997). Identification of Target Genes of the Lymphoid-Specific Transcription Factor Oct2. Immunobiology. 198(1-3). 217–226. 8 indexed citations
12.
Zwilling, Stefan, Andreas Dieckmann, Petra Pfisterer, Peter Angel, & Thomas Wirth. (1997). Inducible Expression and Phosphorylation of Coactivator BOB.1/OBF.1 in T Cells. Science. 277(5323). 221–225. 72 indexed citations
13.
Pfisterer, Petra, Harald König, Jochen Heß, et al.. (1996). CRISP-3, a Protein with Homology to Plant Defense Proteins, Is Expressed in Mouse B Cells under the Control of Oct2. Molecular and Cellular Biology. 16(11). 6160–6168. 59 indexed citations
14.
Wirth, Thomas, et al.. (1995). Molecular Principles of Oct2-Mediated Gene Activation in B Cells. Immunobiology. 193(2-4). 161–170. 22 indexed citations
15.
Pfisterer, Petra, Stefan Zwilling, Jochen Heß, & Thomas Wirth. (1995). Functional Characterization of the Murine Homolog of the B cell-specific Coactivator BOB.1/OBF.1. Journal of Biological Chemistry. 270(50). 29870–29880. 57 indexed citations
16.
König, Harald, Petra Pfisterer, Lynn M. Corcoran, & Thomas Wirth. (1995). Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2.. Genes & Development. 9(13). 1598–1607. 68 indexed citations
17.
Kistler, Barbara, Petra Pfisterer, & Thomas Wirth. (1995). Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.. PubMed. 11(6). 1095–106. 39 indexed citations
18.
Pfisterer, Petra, et al.. (1994). Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.. The EMBO Journal. 13(7). 1654–1663. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Divya Sahu Breakdown of academic impact, for papers by M. Aiman Mohtar Breakdown of academic impact, for papers by Anne Shilkaitis Breakdown of academic impact, for papers by Gitte P. Ratz Breakdown of academic impact, for papers by Ta‐Hsu Chou Breakdown of academic impact, for papers by Anna Jaśkiewicz Breakdown of academic impact, for papers by Yu‐Shan Wang Breakdown of academic impact, for papers by Derek Blair Breakdown of academic impact, for papers by Uri Nir
Rankless by CCL
2026